Skip to main content
. 2022 Feb;33(2):401–419. doi: 10.1681/ASN.2021050643

Table 5c.

Time to relapse: During the follow-up period

Group No. of Patients No. of Patients with Treatment Failure No. of Patients Censored Median (95% CI) (days) Hazard ratio (95% CI)
MMF 28 17 11 249.0 (138.0 to 349.0) 3.513 (1.02 to 12.10)
Placebo 12 3 9 not reached (56.0 to not reached)